Anti-human Semaphorin 4C antibody and application thereof

The invention discloses an anti-human Semaphorin 4C antibody and an application of the anti-human Semaphorin 4C antibody. According to the invention, a series of anti-human SEMA4C antibodies are prepared in the form of immunizing mice. The anti-human SEMA4C antibody can be effectively combined with human SEMA4C protein and can be used for early screening of breast cancer, and a part of the antibody shows a good anti-TNBC subtype breast cancer curative effect in an animal model test..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 05. Jan. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

PIAO JINHUA [VerfasserIn]
WANG GUOYONG [VerfasserIn]
CAO HUAN [VerfasserIn]
LIU YUJIAO [VerfasserIn]
CHEN KAI [VerfasserIn]
GAO ZHAN [VerfasserIn]
WEI TINGTING [VerfasserIn]
GAO XIANG [VerfasserIn]
ZHANG WEI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che
G01N: Investigating or analysing materials by determining (...)
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22

Patentnummer:

CN117343180

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001139142